跳至主要内容
临床试验/ISRCTN18033113
ISRCTN18033113已完成未知

A randomized controlled trial to assess and compare the outcomes of AI-US-CT-guided biopsy, transrectal ultrasound-guided 12-core systematic biopsy, and mpMRI-assisted 12-core systematic biopsy

Science Technology Department of Zhejiang Province0 个研究点目标入组 450 人开始时间: 2016年12月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
450

研究概览

简要总结

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35852595/ (added 11/08/2022)

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 2. Under 85 years of age
  • 3. Verified prostate-specific antigen (PSA) > 4 ng/ml and/or abnormal DRE
  • 4. Provision of signed informed consent

排除标准

  • 1. No signed informed consent
  • 2. Patients who have been included in published cohorts

研究者

发起方
Science Technology Department of Zhejiang Province

相似试验